PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC)

Huddart R. A. , Siefker-Radtke A. O. , Balar A. V. , Bilen M. A. , Powles T., Bamias A., ...Daha Fazla

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38 identifier

  • Cilt numarası: 38
  • Basıldığı Şehir: San-Francisco
  • Basıldığı Ülke: Kostarika